JNJ-54767414
54767414SMM3001
Phase 3 small_molecule active
Quick answer
JNJ-54767414 for Precancerous form of blood cancer in the bone marrow is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Precancerous form of blood cancer in the bone marrow
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active